Motley Fool Wealth Management LLC Sells 8,196 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Motley Fool Wealth Management LLC reduced its stake in The Cooper Companies by 7.8%, selling 8,196 shares during the first quarter, leaving it with 96,407 shares valued at approximately $8.13 million.
• Cooper Companies reported a net revenue of $1 billion for the last quarter, surpassing analysts' expectations of $995.12 million, with earnings per share of $0.96, above the consensus estimate of $0.93.
• Several research analysts have updated their ratings on Cooper Companies, with UBS upgrading it to a "buy" rating, while JPMorgan Chase & Co. set a new price objective of $76.00, down from $110.00.

Motley Fool Wealth Management LLC lessened its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 7.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 96,407 shares of the medical device company's stock after selling 8,196 shares during the period. Motley Fool Wealth Management LLC's holdings in Cooper Companies were worth $8,132,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Zions Bancorporation National Association UT bought a new stake in shares of Cooper Companies during the 1st quarter valued at about $33,000. City Holding Co. bought a new stake in shares of Cooper Companies during the 1st quarter valued at about $34,000. Covestor Ltd boosted its stake in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after purchasing an additional 664 shares in the last quarter. Finally, HM Payson & Co. boosted its stake in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after purchasing an additional 532 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 1.6%

COO opened at $70.29 on Monday. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The firm has a 50 day moving average price of $71.53 and a 200-day moving average price of $79.73. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The stock has a market capitalization of $14.06 billion, a price-to-earnings ratio of 34.12, a PEG ratio of 1.71 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same period in the previous year, the company earned $0.85 earnings per share. The firm's quarterly revenue was up 6.3% on a year-over-year basis. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

COO has been the topic of several research reports. UBS Group raised shares of Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Robert W. Baird dropped their price objective on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research note on Friday, May 30th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Finally, Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research note on Tuesday, June 17th. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.